I recently discovered this information that suggests that Neuroderm and their pump/patch levodopa delivery system may not be all that impressive. Would like some expert analysis from the folks here who can give their opinions. Thanks

Mitsubishi Tanabe Is Making A Huge Mistake: Why We Believe NeuroDerm Is A Lemon - NeuroDerm (NASDAQ:NDRM) | Seeking Alpha